CORC

浏览/检索结果: 共762条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial 期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 18
作者:  Li, Ning;  Zhu, Jianqing;  Yin, Rutie;  Wang, Jing;  Pan, Lingya
收藏  |  浏览/下载:16/0  |  提交时间:2022/12/23
RNA m6A reader YTHDF1 facilitates inflammation via enhancing NLRP3 translation 期刊论文
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 卷号: 616
作者:  Hao, Wei-Yuan;  Lou, Yan;  Hu, Guo-Ying;  Qian, Chao-Yi;  Liang, Wei-Ren
收藏  |  浏览/下载:15/0  |  提交时间:2022/12/23
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li
收藏  |  浏览/下载:26/0  |  提交时间:2022/12/22
A study of AK104 (an anti-PD1 and anti-CTLA4 bispecific antibody) combined with standard therapy for the first-line treatment of persistent, recurrent, or metastatic cervical cancer (R/M CC). 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Wang, Jing;  Lou, Hanmei;  Cai, Hong-Bing;  Huang, Xin;  Li, Guiling
收藏  |  浏览/下载:13/0  |  提交时间:2022/12/23
Exploratory hrd and PD-L1 analysis of l-MOCA study: Olaparib maintenance monotherapy in Asian patients with platinum-sensitive relapsed ovarian cancer. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Ma, Ding;  Gao, Qing-Lei;  Zhu, Jianqing;  Zhao, Weidong;  Huang, Yi
收藏  |  浏览/下载:23/0  |  提交时间:2022/12/23
Material properties of phase-separated TFEB condensates regulate the autophagy-lysosome pathway 期刊论文
JOURNAL OF CELL BIOLOGY, 2022, 卷号: 221, 期号: 5, 页码: 27
作者:  Wang,Zheng;  Chen,Di;  Guan DS(关东石);  Liang,Xiaobo;  Xue,Jianfeng
收藏  |  浏览/下载:12/0  |  提交时间:2022/11/14
Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study 期刊论文
CLINICAL CANCER RESEARCH, 2022, 卷号: 28
作者:  Wu, Xiaohua;  Zhu, Jianqing;  Wang, Jing;  Lin, Zhongqiu;  Yin, Rutie
收藏  |  浏览/下载:102/0  |  提交时间:2022/03/28
Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China 期刊论文
THORACIC CANCER, 2021
作者:  Shi, Yuequan;  Fang, Jian;  Zhou, Chengzhi;  Liu, Anwen;  Wang, Yan
收藏  |  浏览/下载:63/0  |  提交时间:2022/01/25
Oxidation behavior of high Hf nickel-based superalloy in air at 900, 1000 and 1100 degrees C 期刊论文
INTERNATIONAL JOURNAL OF MINERALS METALLURGY AND MATERIALS, 2021, 卷号: 28, 期号: 12, 页码: 1957-1965
作者:  Xiao, Jiu-han;  Xiong, Ying;  Wang, Li;  Jiang, Xiang-wei;  Wang, Dong
收藏  |  浏览/下载:42/0  |  提交时间:2022/01/27
Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial 期刊论文
GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162
作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li
收藏  |  浏览/下载:48/0  |  提交时间:2021/11/01


©版权所有 ©2017 CSpace - Powered by CSpace